Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6456-6462

  Hu, Yu ^a   Wang, Jie ^a   Yang, Bo ^a   Zheng, Nuoyan ^b,c   Qin, Meiling ^a   Ji, Yongyong ^a   Lin, Guomei ^a   Tian, Lin ^a   Wu, Xiaodong ^a   Wu, Li ^b,c   Sun, Bing ^a,d  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c Tsinghua University   (China)

^d INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE BINDING PROTEIN 4; INTERFERON REGULATORY FACTOR 7; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; TRANSACTIVATION; TRANSCRIPTION INITIATION; UBIQUITINATION; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE TARGETING; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; INTERFERON REGULATORY FACTOR-7; INTERFERON-ALPHA; MICE; RECOMBINANT PROTEINS; SENDAI VIRUS; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 83755173110     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003691     Document Type: Article

References (50)

1. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
2. O'Neill, L. A., and A. G. Bowie. 2010. Sensing and signaling in antiviral innate immunity. Curr. Biol. 20: R328-R333.
3. Wilkins, C., and M. Gale, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22: 41-47.
4. Kawai, T., and S. Akira. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143: 1-20.
5. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
6. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603. (Pubitemid 38481202)
7. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531. (Pubitemid 38314425)
8. Krug, A., G. D. Luker, W. Barchet, D. A. Leib, S. Akira, and M. Colonna. 2004. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103: 1433-1437. (Pubitemid 38168659)
9. Krug, A., A. R. French, W. Barchet, J. A. Fischer, A. Dzionek, J. T. Pingel, M. M. Orihuela, S. Akira, W. M. Yokoyama, and M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21: 107-119. (Pubitemid 38925271)
10. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198: 513-520. (Pubitemid 36976063)
11. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737. (Pubitemid 39023305)
12. Andrejeva, J., K. S. Childs, D. F. Young, T. S. Carlos, N. Stock, S. Goodbourn, and R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 101: 17264-17269. (Pubitemid 39627808)
13. Yoneyama, M., and T. Fujita. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227: 54-65.
14. Lei, Y., C. B. Moore, R. M. Liesman, B. P. O'Connor, D. T. Bergstralh, Z. J. Chen, R. J. Pickles, and J. P. Ting. 2009. MAVS-mediated apoptosis and its inhibition by viral proteins. PLoS ONE 4: e5466.
15. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
16. Zhang, M., Y. Tian, R. P. Wang, D. Gao, Y. Zhang, F. C. Diao, D. Y. Chen, Z. H. Zhai, and H. B. Shu. 2008. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Res. 18: 1096-1104.
17. Saitoh, T., M. Yamamoto, M. Miyagishi, K. Taira, M. Nakanishi, T. Fujita, S. Akira, N. Yamamoto, and S. Yamaoka. 2005. A20 is a negative regulator of IFN regulatory factor 3 signaling. J. Immunol. 174: 1507-1512.
18. Saitoh, T., A. Tun-Kyi, A. Ryo, M. Yamamoto, G. Finn, T. Fujita, S. Akira, N. Yamamoto, K. P. Lu, and S. Yamaoka. 2006. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7: 598-605. (Pubitemid 43797341)
19. Higgs, R., J. Ní Gabhann, N. Ben Larbi, E. P. Breen, K. A. Fitzgerald, and C. A. Jefferies. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin- mediated degradation of IRF3. J. Immunol. 181: 1780-1786.
20. Martens, S., and J. Howard. 2006. The interferon-inducible GTPases. Annu. Rev. Cell Dev. Biol. 22: 559-589.
21. MacMicking, J. D. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25: 601-609. (Pubitemid 39369737)
22. Shenoy, A. R., B. H. Kim, H. P. Choi, T. Matsuzawa, S. Tiwari, and J. D. MacMicking. 2007. Emerging themes in IFN-gamma-induced macrophage immunity by the p47 and p65 GTPase families. Immunobiology 212: 771-784. (Pubitemid 350246255)
23. Itsui, Y., N. Sakamoto, S. Kakinuma, M. Nakagawa, Y. Sekine-Osajima, M. Tasaka-Fujita, Y. Nishimura-Sakurai, G. Suda, Y. Karakama, K. Mishima, et al. 2009. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50: 1727-1737.
24. Anderson, S. L., J. M. Carton, J. Lou, L. Xing, and B. Y. Rubin. 1999. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256: 8-14. (Pubitemid 29391821)
25. Carter, C. C., V. Y. Gorbacheva, and D. J. Vestal. 2005. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch. Virol. 150: 1213-1220. (Pubitemid 40772024)
26. Kawai, T., S. Sato, K. J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai M. Matsuda, J. Inoue, S. Uematsu, et al. 2004. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068. (Pubitemid 41057726)
27. Shi, M.,W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X.Wu, Z. Tao, Z. Li, X. Cai, et al. 2008. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9: 369-377. (Pubitemid 351405106)
28. Hou, W., Y. Wu, S. Sun, M. Shi, Y. Sun, C. Yang, G. Pei, Y. Gu, C. Zhong, and B. Sun. 2003. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J. Immunol. 170: 1728-1736. (Pubitemid 36197387)
29. Huang, C., E. Bi, Y. Hu, W. Deng, Z. Tian, C. Dong, Y. Hu, and B. Sun. 2006. A novel NF-kappaB binding site controls human granzyme B gene transcription. J. Immunol. 176: 4173-4181. (Pubitemid 44264397)
30. Friedman, C. S., M. A. O'Donnell, D. Legarda-Addison, A. Ng, W. B. Cárdenas, J. S. Yount, T. M. Moran, C. F. Basler, A. Komuro, C. M. Horvath, et al. 2008. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9: 930-936.
31. Steinberg, C., K. Eisenächer, O. Gross, W. Reindl, F. Schmitz, J. Ruland, and A. Krug. 2009. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Eur. J. Immunol. 39: 1007-1018.
32. Marié, I., E. Smith, A. Prakash, and D. E. Levy. 2000. Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol. Cell. Biol. 20: 8803-8814. (Pubitemid 32245913)
33. Konno, H., T. Yamamoto, K. Yamazaki, J. Gohda, T. Akiyama, K. Semba, H. Goto, A. Kato, T. Yujiri, T. Imai, et al. 2009. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS ONE 4: e5674.
34. Ning, S., A. D. Campos, B. G. Darnay, G. L. Bentz, and J. S. Pagano. 2008. TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol. Cell. Biol. 28: 6536-6546.
35. Salloum, R., B. S. Franek, S. N. Kariuki, L. Rhee, R. A. Mikolaitis, M. Jolly, T. O. Utset, and T. B. Niewold. 2010. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. Arthritis Rheum. 62: 553-561.
36. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25: 373-381. (Pubitemid 44354218)
37. Bonjardim, C. A., P. C. Ferreira, and E. G. Kroon. 2009. Interferons: signaling, antiviral and viral evasion. Immunol. Lett. 122: 1-11.
38. Borden, E. C., G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6: 975-990. (Pubitemid 350201788)
39. Wada, M., H. Marusawa, R. Yamada, A. Nasu, Y. Osaki, M. Kudo, M. Nabeshima, Y. Fukuda, T. Chiba, and F. Matsuda. 2009. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients. J. Viral Hepat. 16: 388-396.
40. Zhong, B., L. Zhang, C. Lei, Y. Li, A. P. Mao, Y. Yang, Y. Y. Wang, X. L. Zhang, and H. B. Shu. 2009. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30: 397-407.
41. Takeuchi, O., and S. Akira. 2009. Innate immunity to virus infection. Immunol. Rev. 227: 75-86.
42. Nakhaei, P., T. Mesplede, M. Solis, Q. Sun, T. Zhao, L. Yang, T. H. Chuang, C. F. Ware, R. Lin, and J. Hiscott. 2009. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 5: e1000650.
43. Li, Y., C. Li, P. Xue, B. Zhong, A. P. Mao, Y. Ran, H. Chen, Y. Y. Wang, F. Yang, and H. B. Shu. 2009. ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc. Natl. Acad. Sci. USA 106: 7945-7950.
44. Yu, Y., S. E. Wang, and G. S. Hayward. 2005. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22: 59-70. (Pubitemid 40143451)
45. Hahn, A. M., L. E. Huye, S. Ning, J. Webster-Cyriaque, and J. S. Pagano. 2005. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 79: 10040-10052. (Pubitemid 41022345)
46. Zhu, F. X., S. M. King, E. J. Smith, D. E. Levy, and Y. Yuan. 2002. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. USA 99: 5573-5578. (Pubitemid 34411590)
47. Uematsu, S., S. Sato, M. Yamamoto, T. Hirotani, H. Kato, F. Takeshita, M. Matsuda, C. Coban, K. J. Ishii, T. Kawai, et al. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-alpha induction. J. Exp. Med. 201: 915-923. (Pubitemid 40524461)
48. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496. (Pubitemid 36592443)
49. Hoshino, K., T. Sugiyama, M. Matsumoto, T. Tanaka, M. Saito, H. Hemmi, O. Ohara, S. Akira, and T. Kaisho. 2006. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440: 949-953.
50. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151. (Pubitemid 36583100)